Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-incisional Infiltration With Ropivacaine Plus Diprospan in VATS
NCT07626489Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- May 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Randomised trial of betamethasone dipropionate + betamethasone sodium phosphate in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Intravenous Morphine Equivalents of Rescue Analgesic Medications at 48 hours. Started May 2026; status: recruiting.
02
Drugs
betamethasone dipropionate + betamethasone sodium phosphate
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07626489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07626489.